We found that NDRG2 could induce GLUT1 protein degradation to decrease glucose uptake in breast cancer cell lines, but whether this regulatory mechanism also functions in the tumour microenvironment must be studied in vivo. This evidence concerns the gene SLC2A1 and breast carcinoma.